OS Therapies, a clinical-stage biopharmaceutical company focused on discovering and developing innovative therapies to treat and cure Osteosarcoma (OS) and other deadly cancers in kids and adults including ovarian, esophageal, endometrial and lung cancers, today announced the closing of a $6 million Series A round of funding.
Who to call at Os Therapies, and when
A new round usually means Os Therapies is about to hire and buy. The teams that reach out first get the meeting.
An alert the day Os Therapies raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Os Therapies, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Os Therapies. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Os Therapies
Location
15825 Shady Grove Road
Grasonville, Maryland, United States
About
OS Therapies is a clinical stage research company focusing on therapeutic treatments for Osteosarcoma, Breast Cancer and other solid tumors with two platform technologies: OST-HER2 to prevent metastasis and OST-tADC to debulk solid tumors.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Os Therapies raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
GrasonvilleBiotechnologyHealthcareHealth CareTherapeuticsPharmaceuticalBiopharma